🇺🇸 ILMN — Illumina, Inc.

Salud Mantener
← Volver

Precio actual

238,21 USD

Máx. histórico

510,54

1905 días

Split 1028:1000 del 25/06/2024

Caída desde máximo

-53,34%

Rango 52 semanas

112,65 – 309,35

Variación hoy

+5,13%

Cierre anterior

226,58

Rango de hoy

229,08 – 241,85

Volumen hoy

2.212.282

Peor caída histórica

-96,14%

01/09/2000 → 13/03/2003

Recuperado en 1595 días

Volatilidad anualizada ⓘ

56,40%

Información
Nombre completo
Illumina, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Diagnostics & Research
Empleados
8.600
PER ⓘ
44,44 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
261,60 USD (puede no estar actualizado)
Primera cotización
28/07/2000
Precio actualizado
hace 12 horas
Sobre la empresa

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2024 1028:1000
23/09/2008 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/04/2024 119,23 121,94 118,78 119,70 -1,35% 2,64% 1.168.836
29/04/2024 120,29 122,72 119,99 121,33 +2,00% 2,27% 934.246
26/04/2024 116,39 120,36 115,73 118,95 +1,02% 3,98% 852.520
25/04/2024 118,65 118,72 113,73 117,75 -1,48% 4,21% 989.758
24/04/2024 119,74 121,34 117,53 119,52 -1,28% 3,18% 1.289.523
23/04/2024 117,53 122,28 117,53 121,07 +3,50% 4,04% 1.339.484
22/04/2024 115,35 117,69 114,28 116,97 +2,40% 2,96% 1.183.434
19/04/2024 114,48 115,97 113,43 114,23 +0,63% 2,22% 1.457.910
18/04/2024 113,08 115,93 112,58 113,51 -1,35% 2,97% 1.860.886
17/04/2024 114,65 116,79 114,22 115,07 +0,51% 2,24% 1.918.556
16/04/2024 115,95 116,30 113,65 114,48 -2,86% 2,29% 1.745.750
15/04/2024 124,79 124,79 117,68 117,86 -4,65% 5,70% 1.661.968
12/04/2024 125,49 131,18 123,00 123,61 -2,78% 6,52% 1.675.126
11/04/2024 128,47 129,58 124,59 127,14 -0,36% 3,88% 1.115.791
10/04/2024 125,40 128,74 124,75 127,60 -1,80% 3,18% 1.921.332
09/04/2024 127,98 131,58 127,17 129,93 +2,65% 3,44% 1.783.888
08/04/2024 124,60 126,99 123,83 126,58 +1,86% 2,54% 1.124.015
05/04/2024 121,64 126,03 120,29 124,27 +1,39% 4,72% 1.131.211
04/04/2024 126,28 127,91 122,44 122,57 -1,36% 4,33% 2.758.638
03/04/2024 123,74 126,55 123,54 124,26 -0,61% 2,43% 1.950.116
02/04/2024 127,59 128,21 124,78 125,02 -3,16% 2,69% 2.020.226
01/04/2024 134,40 134,76 127,74 129,11 -3,35% 5,22% 1.299.700
28/03/2024 134,90 136,25 132,58 133,58 -0,98% 2,73% 942.573
27/03/2024 131,82 134,90 130,81 134,90 +3,65% 3,11% 978.142
26/03/2024 130,77 132,16 129,81 130,16 -0,19% 1,80% 1.158.453
25/03/2024 133,50 133,78 129,15 130,41 -2,32% 3,47% 994.076
22/03/2024 133,29 133,75 130,22 133,50 -0,15% 2,64% 1.331.157
21/03/2024 136,88 140,26 132,70 133,71 +3,20% 5,52% 2.042.842
20/03/2024 129,07 129,66 126,22 129,56 +0,02% 2,67% 1.311.111
19/03/2024 125,37 132,11 124,99 129,53 +2,32% 5,68% 3.140.848